标题
Trabectedin for Soft Tissue Sarcoma: Current Status and Future Perspectives
作者
关键词
Alkylating agent, Clinical trials, Chemotherapy, DNA minor groove binder, ET-743, Oncology, Soft tissue sarcoma, Trabectedin
出版物
ADVANCES IN THERAPY
Volume 33, Issue 7, Pages 1055-1071
出版商
Springer Nature
发表日期
2016-05-27
DOI
10.1007/s12325-016-0344-3
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial
- (2016) George D. Demetri et al. JOURNAL OF CLINICAL ONCOLOGY
- Trabectedin and its potential in the treatment of soft tissue sarcoma
- (2016) J Fayette Therapeutics and Clinical Risk Management
- Trabectedin in patients with advanced soft tissue sarcoma: A retrospective national analysis of the French Sarcoma Group
- (2015) Axel Le Cesne et al. EUROPEAN JOURNAL OF CANCER
- Beyond clinical trials in advanced soft tissue sarcoma: what to expect from trabectedin treatment?
- (2015) Peter Reichardt Future Oncology
- Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study
- (2015) Akira Kawai et al. LANCET ONCOLOGY
- Trabectedin in Soft Tissue Sarcomas
- (2015) Bradley Petek et al. Marine Drugs
- Trabectedin, a drug acting on both cancer cells and the tumour microenvironment
- (2014) M D’Incalci et al. BRITISH JOURNAL OF CANCER
- Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomas
- (2014) Jean-Yves Blay et al. EUROPEAN JOURNAL OF CANCER
- Clinical outcomes and safety with trabectedin therapy in patients with advanced soft tissue sarcomas following failure of prior chemotherapy: results of a worldwide expanded access program study
- (2013) B. L. Samuels et al. ANNALS OF ONCOLOGY
- Efficacy and safety of trabectedin as an early treatment for advanced or metastatic liposarcoma and leiomyosarcoma
- (2013) Jean Yves Blay et al. Future Oncology
- Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
- (2012) Winette TA van der Graaf et al. LANCET
- Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma
- (2011) A. Gronchi et al. ANNALS OF ONCOLOGY
- Predictive impact of DNA repair functionality on clinical outcome of advanced sarcoma patients treated with trabectedin: A retrospective multicentric study
- (2011) P. Schöffski et al. EUROPEAN JOURNAL OF CANCER
- Trabectedin in advanced uterine leiomyosarcomas: A retrospective case series analysis from two reference centers
- (2011) Roberta Sanfilippo et al. GYNECOLOGIC ONCOLOGY
- A phase II evaluation of trabectedin in the treatment of advanced, persistent, or recurrent uterine leiomyosarcoma: A gynecologic oncology group study
- (2011) Bradley J. Monk et al. GYNECOLOGIC ONCOLOGY
- Antitumor and Anti-inflammatory Effects of Trabectedin on Human Myxoid Liposarcoma Cells
- (2010) G. Germano et al. CANCER RESEARCH
- A Review of Trabectedin (ET-743): A Unique Mechanism of Action
- (2010) Maurizio D'Incalci et al. MOLECULAR CANCER THERAPEUTICS
- Phase I and Pharmacokinetic Study of Trabectedin as a 1- or 3-hour Infusion Weekly in Patients with Advanced Solid Malignancies
- (2009) B. Forouzesh et al. CLINICAL CANCER RESEARCH
- Phase I clinical and pharmacokinetic study of trabectedin and cisplatin in solid tumours
- (2009) C. Sessa et al. EUROPEAN JOURNAL OF CANCER
- Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules
- (2009) George D. Demetri et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase I study of the safety and pharmacokinetics of trabectedin in combination with pegylated liposomal doxorubicin in patients with advanced malignancies
- (2008) M. von Mehren et al. ANNALS OF ONCOLOGY
- Phase I trial of weekly trabectedin (ET-743) and gemcitabine in patients with advanced solid tumors
- (2008) Wells A. Messersmith et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase I Combination Study of Trabectedin and Doxorubicin in Patients with Soft-Tissue Sarcoma
- (2008) J.-Y. Blay et al. CLINICAL CANCER RESEARCH
- Phase I clinical and pharmacokinetic study of trabectedin and doxorubicin in advanced soft tissue sarcoma and breast cancer
- (2008) C. Sessa et al. EUROPEAN JOURNAL OF CANCER
- Transcription-coupled DNA Double-Strand Breaks Are Mediated via the Nucleotide Excision Repair and the Mre11-Rad50-Nbs1 Complex
- (2008) Josée Guirouilh-Barbat et al. MOLECULAR BIOLOGY OF THE CELL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now